Published 9 hours ago • loading... • Updated 9 hours ago
Bayer's $7.25 billion Roundup settlement faces new objections
Objectors say the $7.25 billion deal would bind current and future cancer claimants while Bayer seeks federal court review that could derail approval.
On Friday, attorney Ashley Keller filed a motion in the U.S. District Court for the Eastern District of Missouri to move the proposed $7.25 billion Roundup settlement from state to federal court.
Objections filed Thursday in Missouri Circuit Court allege the deal is a "sweetheart deal" that violates the Constitution, with critics citing $675 million in lawyer fees versus minimal compensation for cancer victims.
Critics argue the settlement's "futures" subclass is unconstitutional, binding millions of people—including those not yet conceived—to terms described as "comically difficult" to opt out of.
Attorney Christopher Seeger, representing claimants, denounced the court shift as a "baseless delay tactic," while Bayer stated the move "has no merit" and remains confident in the agreement.
With a June 4 deadline approaching to opt out, the settlement outcome remains uncertain as the Supreme Court weighs a separate case that could block state-level failure-to-warn lawsuits.